Silvia Vannuccini

ORCID: 0000-0001-5790-587X · 116 papers in corpus
review 2024
Best practice & research. Clinical obstetrics & gynaecology ·doi:10.1016/j.bpobgyn.2024.102507

Adenomyosis is a common benign uterine disorders and patients may present dysmenorrhea, dyspareunia, abnormal uterine bleeding (AUB) and infertility. The treatment is very complex, including medical, surgical or radiological approaches. Hor…

observational 2024
·doi:10.1016/j.jeud.2024.100094

• Women with newly diagnosed endometriosis reported an unbalanced dietary pattern. • An unfavorable balance between pro-inflammatory and anti-inflammatory food was found in women with endometriosis. • Patient with endometriosis reported hig…

review 2024
Reproductive BioMedicine Online ·doi:10.1016/j.rbmo.2024.104704

With a growing number of women in developed countries having children later in life, it is time to rethink women's reproductive health. This trend of 'delayed parenthood' reflects a complex interplay of labour market rules, personal choices…

2024
·doi:10.1007/978-3-031-55300-4_9
2024
·doi:10.1007/978-3-031-50662-8_2
review 2024
·doi:10.1016/j.jeud.2024.100105

• Endometriosis with associated mental health symptoms lowers health-related quality of life. • Symptoms of anxiety and depression are associated with a greater number of endometriosis symptoms. • Further research is required and should rep…

observational 2024
Maturitas ·doi:10.1016/j.maturitas.2024.107996

OBJECTIVES: To explore the imaging features and the molecular characterization of adenomyosis after menopause. STUDY DESIGN: An observational cross-sectional study was performed in a group of postmenopausal patients undergoing a transvagin…

review 2024
·doi:10.1016/j.jeud.2024.100079

Iron deficiency (ID) and iron deficiency anemia (IDA) are very common in women during their reproductive life, but often these conditions remain unrecognized and left untreated, particularly in low/ middle income countries (LMICs). Heavy me…

observational 2024
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology ·doi:10.1080/09513590.2024.2336121

BACKGROUND: Dienogest (DNG) improves endometriosis-associated pain (EAP) and patients' quality of life; however, the modern cornerstone of the management of endometriosis is the long-term adherence of the patient to medical treatment. OBJE…

lab-animal 2024
Nature communications ·doi:10.1038/s41467-024-54486-6

Over 60% of women with endometriosis experience abdominopelvic pain and broader pain manifestations, including chronic back pain, fibromyalgia, chronic fatigue, vulvodynia, and migraine. Although the imbalance of proinflammatory mediators, …

lab-animal 2024
·doi:10.21203/rs.3.rs-4045626/v1

Abstract Over 60% of women with endometriosis experience abdominopelvic pain alongside pain in other areas of the body, such as chronic back pain, fibromyalgia and chronic fatigue, vulvodynia, and migraine. Although the imbalance of proinf…

lab-animal 2024
The FEBS journal ·doi:10.1111/febs.17071

Endometriosis is a chronic gynecological syndrome characterized by endometrial cell invasion of the extra-uterine milieu, pelvic pain and infertility. Treatment relies on either symptomatic drugs or hormonal therapies, even though the mecha…

review 2024
Fertility and sterility ·doi:10.1016/j.fertnstert.2024.04.041

Uterine fibroids (UFs) are the most common female benign pelvic tumors, affecting >60% of patients aged 30-44 years. Uterine fibroids are asymptomatic in a large percentage of cases and may be identified incidentally using a transvaginal ul…

review 2024
·doi:10.21608/jrme.2024.260072.1002

Endometriosis, a chronic gynecological disease, affects millions of women worldwide, significantly impacting their quality of life. A reported delay, ranging from 4 to 12 years, exists between the onset of symptoms and the formal diagnosis.…

observational 2023
F1000Research ·doi:10.12688/f1000research.141537.1

BACKGROUND: Sexual health is a major concern in women with endometriosis, however only a few controlled studies have examined this with validated instruments. The effect of hormonal treatments on sexual function in endometriosis is also an …

observational 2023
Reproductive BioMedicine Online ·doi:10.1016/j.rbmo.2023.03.020

RESEARCH QUESTION: Women with endometriosis are frequently affected by headache. How many of these have a clear diagnosis of migraine? Are the different forms of migraine related to the phenotypes and/or characteristics of endometriosis? D…

review 2023
Vitamins and hormones ·doi:10.1016/bs.vh.2023.01.007

Endometriosis is a benign gynecological disease affecting ∼10% of reproductive-aged women and is defined as the presence of endometrial glands and stroma outside the uterine cavity. Endometriosis can cause a variety of health problems, from…

lab-animal 2023
FASEB journal : official publication of the Federation of American Societies for Experimental Biology ·doi:10.1096/fj.202300323r

Endometriosis is a chronic gynecological disease affecting ~10% women in the reproductive age characterized by the growth of endometrial glands and stroma outside the uterine cavity. The inflammatory process has a key role in the initiation…

other 2023
The journal of sexual medicine ·doi:10.1093/jsxmed/qdad004

Journal Article The challenge of endometriosis for female sexual health Get access Silvia Vannuccini, MD, PhD, Silvia Vannuccini, MD, PhD Obstetrics and Gynecology, Careggi University Hospital, Largo Brambilla 3, 50134, Florence, Italy Sear…

other 2022
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology ·doi:10.1080/09513590.2023.2172156

no abstract - editorial

review 2022
Expert opinion on investigational drugs ·doi:10.1080/13543784.2022.2152325

INTRODUCTION: Endometriosis is an estrogen-dependent disease on the background of progesterone resistance. Increased estrogen production, low estrogen metabolization, and altered estrogen receptors (ERs) expression contribute to the hyperes…

review 2022
Human reproduction open ·doi:10.1093/hropen/hoac048

Heavy menstrual bleeding (HMB) has an estimated prevalence of 18-32% but is known to be under-reported due to poor recognition and estimation of menstrual blood loss (MBL). HMB can negatively impact quality of life, affecting social interac…

review 2022
Fertility and sterility ·doi:10.1016/j.fertnstert.2022.07.021

Menstruation is defined as monthly uterine bleeding, regarded as a sign of reproductive health. When characterized by excessive bleeding (heavy menstrual bleeding [HMB]), it may act as a useful clinical marker for diagnosis of reproductive …

2022
·doi:10.31083/j.ceog4907157

Objectives: Endometriosis is an inflammatory disease characterized by a frequent association with gynecologic and systemic comorbidities. Our aim was to evaluate which gynecologic and systemic comorbidities occur in women affected by endome…

review 2022
Current opinion in pharmacology ·doi:10.1016/j.coph.2022.102311

In the past, the primary approach for the treatment of endometriosis was represented by surgery; however, after the introduction of non-invasive diagnosis of endometriosis with the development of imaging technologies, medical treatment beca…